HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.
about
HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV preventionHIV treatment as prevention: contradictory perspectives from dynamic mathematical modelsConceptualizing a Human Right to Prevention in Global HIV/AIDS PolicyGeographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria PolicyAntiretroviral drug costs and prescription patterns in British Columbia, Canada: 1996-2011.Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study.Interpersonal psychotherapy versus treatment as usual for PTSD and depression among Sichuan earthquake survivors: a randomized clinical trial.Optimal allocation of resources in female sex worker targeted HIV prevention interventions: model insights from Avahan in South India.HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.HIV treatment as prevention: the utility and limitations of ecological observation.HIV treatment as prevention: issues in economic evaluation.Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic.Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria.Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.The determinants of HIV treatment costs in resource limited settings.Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study.Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations.Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs.What Determines HIV Prevention Costs at Scale? Evidence from the Avahan Programme in India.PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention.Cost-effectiveness analysis along the continuum of HIV care: how can we optimize the effect of HIV treatment as prevention programs?Programmatic and ethical challenges in the implementation of treatment-as-prevention in the context of HIV and drug-resistant tuberculosis co-infection in sub-Saharan Africa.A Political and Social History of HIV in South Africa.Adherence clubs for long-term provision of antiretroviral therapy: cost-effectiveness and access analysis from Khayelitsha, South Africa.The effects of decentralizing anti-retroviral services in Nigeria on costs and service utilization: two case studies.HIV prevention costs and their predictors: evidence from the ORPHEA Project in Kenya.Reconciling the science and policy divide: The reality of scaling up antiretroviral therapy in South Africa.
P2860
Q26853353-20921DDB-62B8-453E-BDB7-0B57DA8F63DAQ28080917-F7636734-7FEA-4984-BD81-0C4783C74736Q30424601-15388180-CCF7-4BB2-BF15-32EC62A59B21Q33665438-D520CD71-CD41-4014-8B2E-8EC815256777Q33713411-153AE50D-A096-4DE1-8ABE-98A5EB64D81AQ33803388-9E0905B2-D4B3-488C-9D7C-F7945D2FBA49Q34234063-71641E2A-999F-4819-84B7-57C6169A9DCEQ34278022-6BC46A16-65A4-46B2-B779-F80B1CFB03B1Q34339523-4F9805D4-81B6-42C0-BE3A-FF93F1BE8B0AQ34339533-EAC66101-BDBF-414E-9A5D-E31F3E4D851FQ34339555-A7F2921E-D458-49AE-B062-8BFBEC4B66DAQ34379806-8F68482F-6DE1-4FA0-B431-EB275E2C6820Q34993280-F0173679-7743-4DF2-B3F8-5B4C115B88DBQ35006672-D7510491-4571-4619-8E84-D08408FB3915Q35850530-F44F511B-3218-4241-A036-B5E8C418B406Q35962509-8B5A3F9F-5349-41C9-8411-8BD0402596EDQ36286256-AFC4A515-7F8B-47C5-811D-018730F6E604Q36381028-46021EFC-63A7-4F67-898E-684EEB43D2FDQ36487079-80523A3B-4E76-4911-BA72-428F3277D715Q37003069-D8495055-2F83-4253-8F39-524F24FF4ED2Q37003938-53E6EE12-89ED-42B4-9CEF-EDD28EB92794Q37248645-272598C4-F5B7-456B-B197-9E28F92DA821Q37352500-79B94A36-195E-4AAF-806A-EF649A6B8867Q38219957-BB21B4B4-6564-44CE-AD38-F6D0358FEB4AQ38244891-3A096B47-AC48-4E95-AE67-DCA3A76B168DQ38393167-6ECA17D4-715E-4791-8A34-61781B0B2966Q38452167-40DD2FC2-4321-481C-8486-AC68E4CBD9B0Q40701983-7639ECF9-922C-4D3D-B54A-050B3B64B176Q40923436-93F51B69-E1F2-4BD0-B8A2-023227256F33Q46323776-D8DFA523-357D-4CB8-A847-FC13B2990E9DQ53795602-756C140D-5B32-4AE5-8679-7B4F98EF1F79
P2860
HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
HIV treatment as prevention: m ...... the art and future directions.
@ast
HIV treatment as prevention: m ...... the art and future directions.
@en
HIV treatment as prevention: m ...... the art and future directions.
@nl
type
label
HIV treatment as prevention: m ...... the art and future directions.
@ast
HIV treatment as prevention: m ...... the art and future directions.
@en
HIV treatment as prevention: m ...... the art and future directions.
@nl
prefLabel
HIV treatment as prevention: m ...... the art and future directions.
@ast
HIV treatment as prevention: m ...... the art and future directions.
@en
HIV treatment as prevention: m ...... the art and future directions.
@nl
P2860
P1433
P1476
HIV treatment as prevention: m ...... the art and future directions.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PMED.1001247
P407
P577
2012-07-10T00:00:00Z